BIO-FD&C Co.,Ltd. (KOSDAQ:251120)

South Korea · Delayed Price · Currency is KRW

8,870.00

+50.00 (0.57%)

At close: Sep 3, 2026

Market Cap	78.26B -50.9%
Revenue (ttm)	19.53B +12.6%
Net Income	6.41B +3.1%
EPS	750.04 +2.9%
Shares Out	8.70M
PE Ratio	12.00
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,050
Open	8,750.00
Previous Close	8,820.00
Day's Range	8,650.00 - 8,990.00
52-Week Range	6,330.00 - 19,450.00
Beta	0.38
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About BIO-FD&C

BIO-FD&C Co.,Ltd. develops active ingredients for anti-aging cosmetics in South Korea. It offers plant cell, peptide, natural extract, and biomolecule products for wrinkle improvement/skin regeneration, skin brightening, acne, skin irritation, wound healing, scalp improvement, skin moisturizing, fine dust, hair loss improvement, pores, lifting, whitening, skin texture, anti-inflammation/skin soothing, and anti-oxidation. The company was founded in 2005 and is headquartered in Incheon, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances

Founded 2005

Country South Korea

Stock Exchange KOSDAQ

Ticker Symbol 251120

Full Company Profile

Financial Performance

In 2025, BIO-FD&C's revenue was 19.18 billion, an increase of 19.37% compared to the previous year's 16.07 billion. Earnings were 6.67 billion, an increase of 48.11%.

Financial Statements